ArticleNeuropharmacology2020

The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.

Malte Feja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.